|  | Total | ART (−) patients | ART (+) patients | Pvalues | ||||
---|---|---|---|---|---|---|---|---|---|
 |  | n | % | n | % | n | % |  |  |
All NHL cases | Â | 71 | 100.0% | 41 | 100.0% | 25 | 100.0% | Â | Â |
 Histology | DLBCL | 53 | 74.6% | 30 | 73.2% | 18 | 72.0% | 0.917 |  |
 | BL | 4 | 5.6% | 3 | 7.3% | 1 | 4.0% | 0.987 | Y |
 | PEL | 5 | 7.0% | 4 | 9.8% | 1 | 4.0% | 0.706 | Y |
 | PBL | 1 | 1.4% | 1 | 2.4% | 0 | 0.0% | 0.801 | Y |
 | Other | 6 | 8.5% | 2 | 4.9% | 4 | 16.0% | 0.279 | Y |
 | Unknown | 2 | 2.8% | 1 | 2.4% | 1 | 4.0% | 0.703 | Y |
 Site | Nodular | 1 | 1.4% | 0 | 0.0% | 1 | 4.0% | 0.801 | Y |
 | Extranodular | 45 | 63.4% | 28 | 68.3% | 12 | 48.0% | 0.102 |  |
 | Both | 21 | 29.6% | 11 | 26.8% | 10 | 40.0% | 0.265 |  |
 | Unknown | 4 | 5.6% | 2 | 4.9% | 2 | 8.0% | 0.987 | Y |
 PCNS | Yes | 27 | 38.0% | 18 | 43.9% | 6 | 24.0% | 0.103 |  |
 EBV | Positive | 52 | 73.2% | 35 | 85.4% | 12 | 48.0% | 0.001 |  |
 KSHV | Positive | 6 | 8.5% | 5 | 12.2% | 1 | 4.0% | 0.495 | Y |
 Cause of death | Yes | 50 | 70.4% | 33 | 80.5% | 16 | 64.0% | 0.137 |  |
All KS cases | Â | 38 | Â | 22 | Â | 10 | Â | Â | Â |
 Site | Skin | 32 | 84.2% | 19 | 86.4% | 9 | 90.0% | 0.410 |  |
 | GI tract | 27 | 71.1% | 15 | 68.2% | 8 | 80.0% | 0.705 |  |
 | Lung | 21 | 55.3% | 11 | 50.0% | 6 | 60.0% | 0.799 |  |
 | Lymph node | 20 | 52.6% | 13 | 59.1% | 6 | 60.0% | 0.502 |  |
 | Other | 16 | 42.1% | 0 | 0.0% | 0 | 0.0% | 0.787 | Y |
 Cause of death | Yes | 11 | 29.0% | 7 | 31.8% | 2 | 20.0% | 0.791 | Y |